Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 302 followers

Latest posts

Last updated about 12 hours ago

Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation: 27/06/2025, Revision: 1, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation...

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 47, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation...

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

about 12 hours ago

List of European Union reference dates (EURD) and frequency of submission of...

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 29, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation...

Medicine shortages and availability issues: guidance for companies

about 12 hours ago

Medicine shortages and availability issues: guidance for companies

Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report

about 12 hours ago

Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report

Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals

about 12 hours ago

Concept Paper on the revision of Annex 3 of the guidelines on...

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 25, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation...

Overview of (invented) names reviewed in November 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 11 November 2025

about 12 hours ago

Overview of (invented) names reviewed in November 2025 by the Name Review...